| Identification of a reservoir for HIV-1 in patients on highly active antiretroviral therapy D Finzi, M Hermankova, T Pierson, LM Carruth, C Buck, RE Chaisson, ... Science 278 (5341), 1295-1300, 1997 | 2815 | 1997 |
| Latent infection of CD4+ T cells provides a mechanism for lifelong persistence of HIV-1, even in patients on effective combination therapy D Finzi, J Blankson, JD Siliciano, JB Margolick, K Chadwick, T Pierson, ... Nature medicine 5 (5), 512, 1999 | 2083 | 1999 |
| Targeted tuberculin testing and treatment of latent tuberculosis infection Centers for Disease Control and Prevention Mmwr 49 (6), 1-54, 2000 | 1308 | 2000 |
| Hepatotoxicity associated with antiretroviral therapy in adults infected with human immunodeficiency virus and the role of hepatitis C or B virus infection MS Sulkowski, DL Thomas, RE Chaisson, RD Moore Jama 283 (1), 74-80, 2000 | 1168 | 2000 |
| Highly active antiretroviral therapy in a large urban clinic: risk factors for virologic failure and adverse drug reactions GM Lucas, RE Chaisson, RD Moore Annals of internal medicine 131 (2), 81-87, 1999 | 990 | 1999 |
| 1997USPHS/IDSA Guidelines for the Prevention of Opportunistic Infections in Persons Infected with Human Immunodeficiency Virus JE Kaplan, H Masur, KK Holmes MMWR Morb Mortal Wkly Rep 48, 1-59, 1999 | 846* | 1999 |
| American thoracic society/centers for disease control and prevention/infectious diseases society of America: treatment of tuberculosis HM Blumberg, WJ Burman, RE Chaisson, CL Daley American journal of respiratory and critical care medicine 167 (4), 603, 2003 | 822 | 2003 |
| Tuberculosis and diabetes mellitus: convergence of two epidemics KE Dooley, RE Chaisson The Lancet infectious diseases 9 (12), 737-746, 2009 | 817 | 2009 |
| Guidelines for preventing opportunistic infections among HIV-infected persons—2002: recommendations of the US Public Health Service and the Infectious Diseases Society of America JE Kaplan, KK Holmes Annals of internal medicine 137 (5_Part_2), 435-478, 2002 | 769 | 2002 |
| Cocaine use and HIV infection in intravenous drug users in San Francisco RE Chaisson, P Bacchetti, D Osmond, B Brodie, MA Sande, AR Moss Jama 261 (4), 561-565, 1989 | 745 | 1989 |
| Seropositivity for HIV and the development of AIDS or AIDS related condition: three year follow up of the San Francisco General Hospital cohort AR Moss, P Bacchetti, D Osmond, W Krampf, RE Chaisson, D Stites, ... Br Med J (Clin Res Ed) 296 (6624), 745-750, 1988 | 713 | 1988 |
| Incidence and natural history of cytomegalovirus disease in patients with advanced human immunodeficiency virus disease treated with zidovudine JE Gallant, RD Moore, DD Richman, J Keruly, RE Chaisson, ... Journal of Infectious Diseases 166 (6), 1223-1227, 1992 | 681 | 1992 |
| Three months of rifapentine and isoniazid for latent tuberculosis infection TR Sterling, ME Villarino, AS Borisov, N Shang, F Gordin, ... New England Journal of Medicine 365 (23), 2155-2166, 2011 | 668 | 2011 |
| Hepatotoxicity associated with nevirapine or efavirenz‐containing antiretroviral therapy: role of hepatitis C and B infections MS Sulkowski, DL Thomas, SH Mehta, RE Chaisson, RD Moore Hepatology 35 (1), 182-189, 2002 | 665 | 2002 |
| Tuberculosis in patients with the acquired immunodeficiency syndrome RE Chaisson, GF Schecter, CP Theuer, GW Rutherford, DF Echenberg, ... Am Rev Respir Dis 136, 570-574, 1987 | 632 | 1987 |
| Treatment of tuberculosis in patients with advanced human immunodeficiency virus infection PM Small, GF Schecter, PC Goodman, MA Sande, RE Chaisson, ... New England Journal of Medicine 324 (5), 289-294, 1991 | 593 | 1991 |
| Hepatitis C and progression of HIV disease MS Sulkowski, RD Moore, SH Mehta, RE Chaisson, DL Thomas Jama 288 (2), 199-206, 2002 | 578 | 2002 |
| Natural history of HIV infection in the_era of combination antiretroviral therapy RD Moore, RE Chaisson Aids 13 (14), 1933-1942, 1999 | 547 | 1999 |
| Official American thoracic society/centers for disease control and prevention/infectious diseases society of America clinical practice guidelines: treatment of drug-susceptible … P Nahid, SE Dorman, N Alipanah, PM Barry, JL Brozek, A Cattamanchi, ... Clinical Infectious Diseases 63 (7), e147-e195, 2016 | 469 | 2016 |
| Two controlled trials of rifabutin prophylaxis against Mycobacterium avium complex infection in AIDS SD Nightingale, DW Cameron, FM Gordin, PM Sullam, DL Cohn, ... New England Journal of Medicine 329 (12), 828-833, 1993 | 440 | 1993 |
Jonathan GolubAssociate Professor, Johns Hopkins UniversityVerified email at jhmi.edu
